Top

Published in:

Open Access 01-04-2011 | Original

Headache in juvenile myoclonic epilepsy

Authors: Christoph J. Schankin, Jan Rémi, Ira Klaus, Petra Sostak, Veronika M. Reinisch, Soheyl Noachtar, Andreas Straube

Published in: The Journal of Headache and Pain | Issue 2/2011

Abstract

The objective of this study was to assess the prevalence of and risk factors for primary headaches in juvenile myoclonic epilepsy (JME). Headache was classified in 75 patients with JME using a questionnaire, and its prevalence was correlated with the literature on the general population and clinical data. Headache was present in 47 patients. Thirty-one had migraine [20 migraine without aura (MO), 11 migraine with aura (MA)]. Fourteen patients with migraine had tension-type headache (TTH) in addition. Sixteen had only TTH. Comparison with the general population revealed a significantly higher prevalence of migraine (RR 4.4), MO (3.6), MA (7.3) and TTH (3.4) in JME. Risk factors for migraine and MO were female gender and for MA family history of migraine in first-degree relatives. Migraine and MA were associated with fairly controlled generalized tonic clonic seizures, MO with absences. Together with its strong genetic background, JME appears to be an attractive homogenous subtype of epilepsy for genetic research on migraine.

Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 5(2):148–157, 16426991, 10.1016/S1474-4422(06)70348-9PubMedCentralCrossRefPubMed

Ottman R, Lipton RB (1994) Comorbidity of migraine and epilepsy. Neurology 44(11):2105–2110, 7969967, 1:STN:280:DyaK2M%2FlvF2quw%3D%3DCrossRefPubMed

Yankovsky AE, Andermann F, Bernasconi A (2005) Characteristics of headache associated with intractable partial epilepsy. Epilepsia 46(8):1241–1245, 16060934, 10.1111/j.1528-1167.2005.64804.xCrossRefPubMed

Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):1–160

Forderreuther S, Henkel A, Noachtar S, Straube A (2002) Headache associated with epileptic seizures: epidemiology and clinical characteristics. Headache 42(7):649–655, 12482219, 10.1046/j.1526-4610.2002.02154.xCrossRefPubMed

Alfradique I, Vasconcelos MM (2007) Juvenile myoclonic epilepsy. Arq Neuropsiquiatr 65(4B):1266–1271, 18345445CrossRefPubMed

Hauser WA, Annegers JF, Rocca WA (1996) Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 71(6):576–586, 8642887, 10.4065/71.6.576, 1:STN:280:DyaK283jt1aluw%3D%3DCrossRefPubMed

Delgado-Escueta AV, Enrile-Bacsal F (1984) Juvenile myoclonic epilepsy of Janz. Neurology 34(3):285–294, 6422321, 1:STN:280:DyaL2c7kt1KgsA%3D%3DCrossRefPubMed

Dhanuka AK, Jain BK, Daljit S, Maheshwari D (2001) Juvenile myoclonic epilepsy: a clinical and sleep EEG study. Seizure 10(5):374–378, 11488650, 10.1053/seiz.2001.0522, 1:STN:280:DC%2BD3MvksVaktA%3D%3DCrossRefPubMed

10.

Liu AW, Delgado-Escueta AV, Gee MN, Serratosa JM, Zhang QW, Alonso ME, Medina MT, Cordova S, Zhao HZ, Spellman JM, Donnadieu FR, Peek JR, Treiman LJ, Sparkes RS (1996) Juvenile myoclonic epilepsy in chromosome 6p12-p11: locus heterogeneity and recombinations. Am J Med Genet 63(3):438–446, 8737649, 10.1002/(SICI)1096-8628(19960614)63:3<438::AID-AJMG5>3.0.CO;2-N, 1:STN:280:DyaK28zmtlOqtA%3D%3DCrossRefPubMed

11.

Welty TE (2006) Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management. Paediatr Drugs 8(5):303–310, 17037947, 10.2165/00148581-200608050-00003CrossRefPubMed

12.

Canevini MP, Mai R, Di Marco C, Bertin C, Minotti L, Pontrelli V, Saltarelli A, Canger R (1992) Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients. Seizure 1(4):291–298, 1344779, 10.1016/1059-1311(92)90039-4, 1:STN:280:DyaK2c3hsV2itw%3D%3DCrossRefPubMed

13.

Montalenti E, Imperiale D, Rovera A, Bergamasco B, Benna P (2001) Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients. J Neurol Sci 184(1):65–70, 11231034, 10.1016/S0022-510X(00)00496-2, 1:STN:280:DC%2BD3M3os1Ojug%3D%3DCrossRefPubMed

14.

Appleton R, Beirne M, Acomb B (2000) Photosensitivity in juvenile myoclonic epilepsy. Seizure 9(2):108–111, 10845733, 10.1053/seiz.1999.0376, 1:STN:280:DC%2BD3cvgtFOluw%3D%3DCrossRefPubMed

15.

International League Against Epilepsy (2003) Juvenile myoclonic epilepsy. Accessed 14 November 2010. http://www.ilae-epilepsy.org/Visitors/Centre/ctf/juvenilemyoclonic.html

16.

Fritsche G, Hueppe M, Kukava M, Dzagnidze A, Schuerks M, Yoon MS, Diener HC, Katsarava Z (2007) Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache 47(4):546–551, 17445104, 10.1111/j.1526-4610.2007.00758.xCrossRefPubMed

17.

Yoon MS, Obermann M, Fritsche G, Slomke M, Dommes P, Schilf C, Diener HC, Katsarava Z (2008) Population-based validation of a German-language self-administered headache questionnaire. Cephalalgia 28(6):605–608, 18422724, 10.1111/j.1468-2982.2008.01560.xCrossRefPubMed

18.

Lampl C, Buzath A, Baumhackl U, Klingler D (2003) One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 23(4):280–286, 12716346, 10.1046/j.1468-2982.2003.00509.x, 1:STN:280:DC%2BD3s7pslWgug%3D%3DCrossRefPubMed

19.

Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig KH, Evers S, Straube A, Hoffmann W, Berger K (2009) Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG headache study. Cephalalgia 29(1):48–57, 18771491, 10.1111/j.1468-2982.2008.01699.x, 1:STN:280:DC%2BD1M%2FlsVChtA%3D%3DCrossRefPubMed

20.

Sjaastad O, Bakketeig L (2008) Tension-type headache: comparison with migraine without aura and cervicogenic headache. The VAGA study of headache epidemiology. Funct Neurol 23(2):71–76, 18671906, 1:STN:280:DC%2BD1cnjsVOgsg%3D%3DPubMed

21.

Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7(4):354–361, 18339350, 10.1016/S1474-4422(08)70062-0CrossRefPubMed

22.

Andermann E, Andermann F, Lugaresi E (1987) Migraine–epilepsy relationships: epidemiological and genetic aspects. In: Migraine and epilepsy. Butterworth, Boston, pp 281–291

23.

Velioglu SK, Ozmenoglu M (1999) Migraine-related seizures in an epileptic population. Cephalalgia 19(9):797–801, 10595289, 10.1046/j.1468-2982.1999.1909797.x, 1:STN:280:DC%2BD3c%2FmtFKltg%3D%3DCrossRefPubMed

24.

Lipton RB, Ottman R, Ehrenberg BL, Hauser WA (1994) Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44(10 Suppl 7):S28–S32, 7969943, 1:STN:280:DyaK2M%2FlvF2ktw%3D%3DPubMed

25.

Stevenson SB (2006) Epilepsy and migraine headache: is there a connection? J Pediatr Health Care 20(3):167–171, 16675377, 10.1016/j.pedhc.2005.10.014CrossRefPubMed

26.

Syvertsen M, Helde G, Stovner LJ, Brodtkorb E (2007) Headaches add to the burden of epilepsy. J Headache Pain 8(4):224–230, 17901922, 10.1007/s10194-007-0398-3PubMedCentralCrossRefPubMed

27.

Clarke T, Baskurt Z, Strug LJ, Pal DK (2009) Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 50(11):2428–2433, 19674062, 10.1111/j.1528-1167.2009.02240.xCrossRefPubMed

28.

Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59(4):652–661, 16450381, 10.1002/ana.20778, 1:CAS:528:DC%2BD28XktFWjsrY%3DCrossRefPubMed

29.

Chalaupka FD (2008) Reversible imaging abnormalities consistent with CSD during migraine without aura attack. Headache 48(8):1229–1232, 18819183, 10.1111/j.1526-4610.2008.01184.xCrossRefPubMed

30.

Parisi P (2009) Why is migraine rarely, and not usually, the sole ictal epileptic manifestation? Seizure 18(5):309–312, 19223208, 10.1016/j.seizure.2009.01.010CrossRefPubMed

31.

Parisi P (2009) Who’s still afraid of the link between headache and epilepsy? Some reactions to and reflections on the article by Marte Helene Bjork and co-workers. J Headache Pain 10(5):327–329, 19705058, 10.1007/s10194-009-0149-8PubMedCentralCrossRefPubMed

32.

Parisi P, Kasteleijn-Nolst Trenite DG, Piccioli M, Pelliccia A, Luchetti A, Buttinelli C, Villa MP (2007) A case with atypical childhood occipital epilepsy “Gastaut type”: an ictal migraine manifestation with a good response to intravenous diazepam. Epilepsia 48(11):2181–2186, 17711460, 10.1111/j.1528-1167.2007.01265.xCrossRefPubMed

33.

Brodtkorb E, Bakken IJ, Sjaastad O (2008) Comorbidity of migraine and epilepsy in a Norwegian community. Eur J Neurol 15(12):1421–1423, 19049567, 10.1111/j.1468-1331.2008.02353.x, 1:STN:280:DC%2BD1cjotFyhtA%3D%3DCrossRefPubMed

34.

Ludvigsson P, Hesdorffer D, Olafsson E, Kjartansson O, Hauser WA (2006) Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 59(1):210–213, 16374824, 10.1002/ana.20745CrossRefPubMed

Title: Headache in juvenile myoclonic epilepsy
Authors: Christoph J. Schankin
Jan Rémi
Ira Klaus
Petra Sostak
Veronika M. Reinisch
Soheyl Noachtar
Andreas Straube
Publication date: 01-04-2011
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 2/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-011-0332-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Headache in juvenile myoclonic epilepsy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)

Effects of anandamide in migraine: data from an animal model

Manual therapies for migraine: a systematic review

Tribute to Pasquale Montagna, 1950–2010

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

Evidence for an association between migraine and the hypocretin receptor 1 gene